Report cover image

Global Natural Killer Cell Therapy Market 2022 - Snapshot

Publisher Gen Consulting Company
Published Sep 29, 2022
Length 60 Pages
SKU # GCC17473255

Description

Global Natural Killer Cell Therapy Market 2022 - Snapshot

The global natural killer cell therapy market is projected to expand at a CAGR of ~36.8 percent across the forecast period of 2022 - 2028, according to the latest edition of the Global Natural Killer Cell Therapy Market Report.

This industry report offers market estimates of the global market, followed by a detailed analysis of the therapy type, indication, and region. The global market data on natural killer cell therapy can be segmented by therapy type: CAR-NK cell therapy (modified), NK cell engager, NK cell therapy (unmodified). Natural killer cell therapy market is further segmented by indication: acute myeloid leukemia (AML), hepatocellular carcinoma (HCC), peripheral T-cell lymphoma (PTCL), relapsed/refractory (R/R) B-cell non-Hodgkin’s lymphoma (NHL). Based on region, the natural killer cell therapy market is segmented into: Asia Pacific, Europe, North America.

The global natural killer cell therapy market is highly competitive. Top players covered in Global Natural Killer Cell Therapy Market Study are Acepodia Inc., Affimed N.V., Celularity Inc., Century Therapeutics Inc., Cytovac A/S, Dragonfly Therapeutics Inc., Fate Therapeutics Inc., Gamida-Cell Ltd., GC Biopharma Corp., Glycostem Therapeutics B.V., iCell Gene Therapeutics LLC, ImmunityBio Inc., Innate Pharma S.A., Nkarta Inc., Sanofi S.A., Senti Biosciences Inc., Shoreline Biosciences Inc., Takeda Pharmaceutical Company Limited, VaxCell Biotherapeutics Co. Ltd.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?
  • Get a detailed picture of the Global Natural Killer Cell Therapy Market
  • Identify segments/areas to invest in over the forecast period in the Global Natural Killer Cell Therapy Market
  • Understand the competitive environment, the market’s leading players
  • The market estimate for ease of analysis across scenarios in Excel format.
  • Strategy consulting and research support for three months.
  • Print authentication provided for the single-user license.

Table of Contents

60 Pages
Part 1. Summary
Part 2. Introduction
Study period
Geographical scope
Market segmentation
Part 3. Natural killer cell therapy market overview
Part 4. Market breakdown by therapy type
CAR-NK cell therapy (modified)
NK cell engager
NK cell therapy (unmodified)
Part 5. Market breakdown by indication
Acute myeloid leukemia (AML)
Hepatocellular carcinoma (HCC)
Peripheral T-cell lymphoma (PTCL)
Relapsed/refractory (R/R) B-cell non-Hodgkin’s lymphoma (NHL)
Part 6. Market breakdown by region
Asia Pacific
Europe
North America
Part 7. Key companies
Acepodia Inc.
Affimed N.V.
Celularity Inc.
Century Therapeutics, Inc.
Cytovac A/S
Dragonfly Therapeutics, Inc.
Fate Therapeutics, Inc.
Gamida-Cell Ltd.
GC Biopharma Corp.
Glycostem Therapeutics B.V.
iCell Gene Therapeutics, LLC
ImmunityBio, Inc.
Innate Pharma S.A.
Nkarta, Inc.
Sanofi S.A.
Senti Biosciences, Inc.
Shoreline Biosciences, Inc.
Takeda Pharmaceutical Company Limited
VaxCell Biotherapeutics Co., Ltd.
Part 8. Methodology

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us